NasdaqGM - Nasdaq Real Time Price USD
Third Harmonic Bio, Inc. (THRD)
5.20
-0.01
(-0.19%)
At close: May 20 at 4:00:00 PM EDT
5.20
0.00
(0.00%)
After hours: May 20 at 4:05:10 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | -0.24 | -0.17 | -0.89 | -1.01 |
| Low Estimate | -0.24 | -0.17 | -0.89 | -1.01 |
| High Estimate | -0.24 | -0.17 | -0.89 | -1.01 |
| Year Ago EPS | -0.22 | -0.33 | -1.09 | -0.89 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 2 | 2 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | -0.26 | -0.29 | -0.33 | -0.3 |
| EPS Actual | -0.22 | -0.33 | -0.29 | -0.35 |
| Difference | 0.04 | -0.04 | 0.04 | -0.05 |
| Surprise % | 16.45% | -13.79% | 12.12% | -16.67% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.24 | -0.17 | -0.89 | -1.01 |
| 7 Days Ago | -0.23 | -0.22 | -0.95 | -0.94 |
| 30 Days Ago | -0.25 | -0.25 | -1.04 | -1.13 |
| 60 Days Ago | -0.26 | -0.25 | -0.94 | -0.93 |
| 90 Days Ago | -0.31 | -0.29 | -1.46 | -1.67 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | 1 | 1 | 1 |
| Up Last 30 Days | 1 | 1 | 1 | 1 |
| Down Last 7 Days | -- | -- | -- | 1 |
| Down Last 30 Days | -- | -- | -- | 1 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| THRD | -9.09% | 48.48% | 18.35% | -13.48% |
| S&P 500 | 13.32% | 2.69% | 7.77% | 13.75% |
Upgrades & Downgrades
| Downgrade | Stifel: Buy to Hold | 3/28/2025 |
| Downgrade | Morgan Stanley: Overweight to Equal-Weight | 2/12/2025 |
| Downgrade | Raymond James: Outperform to Market Perform | 2/11/2025 |
| Upgrade | Morgan Stanley: Equal-Weight to Overweight | 8/9/2024 |
| Initiated | Stifel: Buy | 6/18/2024 |
| Initiated | Raymond James: Outperform | 6/7/2024 |
Related Tickers
CRGX CARGO Therapeutics, Inc.
4.1000
+0.24%
PRTC PureTech Health plc
17.43
+3.74%
TYRA Tyra Biosciences, Inc.
9.98
+3.10%
PRTC.L PureTech Health plc
129.40
+1.09%
KROS Keros Therapeutics, Inc.
14.14
+0.28%
JBIO Jade Biosciences, Inc.
7.72
+3.98%
TCRX TScan Therapeutics, Inc.
1.2100
-2.42%
ACRV Acrivon Therapeutics, Inc.
1.2500
+5.93%
LENZ LENZ Therapeutics, Inc.
28.73
+0.98%
RLYB Rallybio Corporation
0.3458
-0.35%